Corneal cross-linking faces various regulatory hurdles in US

SAN FRANCISCO — Corneal collagen cross-linking faces numerous regulatory approvals in the United States by virtue of being a drug-device combination, an expert said here.The procedure is approved in the European Union and other regions but is not approved in the U.S. Several clinical trials are ongoing.

Full Story →